P. Venkatesan

682 total citations
29 papers, 536 citations indexed

About

P. Venkatesan is a scholar working on Pharmaceutical Science, Analytical Chemistry and Pharmacology. According to data from OpenAlex, P. Venkatesan has authored 29 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmaceutical Science, 7 papers in Analytical Chemistry and 6 papers in Pharmacology. Recurrent topics in P. Venkatesan's work include Drug Solubulity and Delivery Systems (8 papers), Analytical Methods in Pharmaceuticals (7 papers) and Analytical Chemistry and Chromatography (5 papers). P. Venkatesan is often cited by papers focused on Drug Solubulity and Delivery Systems (8 papers), Analytical Methods in Pharmaceuticals (7 papers) and Analytical Chemistry and Chromatography (5 papers). P. Venkatesan collaborates with scholars based in India, United States and Portugal. P. Venkatesan's co-authors include Mahitosh Mandal, Devanand Sarkar, Paul B. Fisher, B. N. Prashanth Kumar, Subhas C. Kundu, Rupesh Dash, Nagaprasad Puvvada, Belal Azab, Amita Pathak and Valliappan Kannappan and has published in prestigious journals such as Biomaterials, Life Sciences and International Journal of Biological Macromolecules.

In The Last Decade

P. Venkatesan

24 papers receiving 501 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Venkatesan India 11 158 124 114 89 59 29 536
Nikola Geškovski North Macedonia 14 127 0.8× 82 0.7× 94 0.8× 135 1.5× 36 0.6× 66 541
Gamal Zayed Egypt 17 177 1.1× 102 0.8× 107 0.9× 253 2.8× 67 1.1× 40 619
Muhammad Tayyab Ansari Pakistan 16 97 0.6× 85 0.7× 208 1.8× 225 2.5× 76 1.3× 43 634
Renuka S. Managuli India 14 144 0.9× 72 0.6× 167 1.5× 330 3.7× 46 0.8× 18 726
Young‐Guk Na South Korea 18 175 1.1× 119 1.0× 193 1.7× 348 3.9× 92 1.6× 47 795
Ahmed N. Allam Egypt 16 130 0.8× 54 0.4× 160 1.4× 225 2.5× 38 0.6× 24 574
Pahweenvaj Ratnatilaka Na Bhuket Thailand 14 230 1.5× 84 0.7× 184 1.6× 183 2.1× 49 0.8× 21 691
Bashar Al-Taani Jordan 14 109 0.7× 56 0.5× 73 0.6× 242 2.7× 35 0.6× 34 470
Bader B. Alsulays Saudi Arabia 18 123 0.8× 100 0.8× 191 1.7× 391 4.4× 101 1.7× 29 737
Ankitkumar S. Jain India 10 136 0.9× 57 0.5× 139 1.2× 202 2.3× 45 0.8× 12 429

Countries citing papers authored by P. Venkatesan

Since Specialization
Citations

This map shows the geographic impact of P. Venkatesan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Venkatesan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Venkatesan more than expected).

Fields of papers citing papers by P. Venkatesan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Venkatesan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Venkatesan. The network helps show where P. Venkatesan may publish in the future.

Co-authorship network of co-authors of P. Venkatesan

This figure shows the co-authorship network connecting the top 25 collaborators of P. Venkatesan. A scholar is included among the top collaborators of P. Venkatesan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Venkatesan. P. Venkatesan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Venkatesan, P., et al.. (2024). Nanocochleates: Versatile Nanostructures for Enhanced Drug Delivery and Therapeutics. International Journal of Pharmaceutical Investigation. 15(1). 49–56.
2.
Venkatesan, P., et al.. (2024). OPTIMIZATION OF LC-MS/MS METHOD FOR THE SIMULTANEOUS DETERMINATION OF METFORMIN AND ROSIGLITAZONE IN HUMAN PLASMA WITH BOX-BEHNKEN DESIGN. International Journal of Applied Pharmaceutics. 98–105.
4.
Selvamuthukumar, Subramanian, et al.. (2023). Cross-Linked β-Cyclodextrin Based Nanosponges for Allyl Methyl Sulfide Delivery-Physicochemical Characterization and In Vitro Study. Journal of Pharmaceutical Innovation. 18(4). 1594–1601.
5.
Selvamuthukumar, Subramanian, et al.. (2023). Cyclodextrin‐based nanosponges as promising carriers for active pharmaceutical ingredient. Journal of Biochemical and Molecular Toxicology. 38(1). 7 indexed citations
7.
Jaganathan, Kowshik, et al.. (2019). Astaxanthin inhibits hallmarks of cancer by targeting the PI3K/NF‐κΒ/STAT3 signalling axis in oral squamous cell carcinoma models. IUBMB Life. 71(10). 1595–1610. 43 indexed citations
9.
Venkatesan, P., et al.. (2017). Evaluation of antidiabetic activity of Miglitol nanoparticles in Streptozotocin induced diabetic rats. 8(1). 103–108. 1 indexed citations
10.
Venkatesan, P., et al.. (2015). Multicriteria optimization of an liquid chromatographic method for the simultaneous separationand estimation of zaltoprofen and paracetamol in human plasma sample: Application of chemometric protocols. Der pharmacia lettre. 7(10). 262–269. 1 indexed citations
11.
Venkatesan, P., et al.. (2014). A study on Methicillin resistant Staphylococcus aureus mastitis in dairy cows. Journal of Applied and Natural Science. 6(2). 356–361. 7 indexed citations
12.
Marslin, Gregory, et al.. (2014). Barringtonia acutangula improves the biochemical parameters in diabetic rats. Chinese Journal of Natural Medicines. 12(2). 126–130. 5 indexed citations
14.
Marslin, Gregory, et al.. (2013). Anti–ulcer activity of Ficus religiosa leaf ethanolic extract. Asian Pacific Journal of Tropical Biomedicine. 3(7). 554–556. 46 indexed citations
15.
Venkatesan, P., Sujit K. Bhutia, Abhay K. Singh, et al.. (2012). AEE788 potentiates celecoxib-induced growth inhibition and apoptosis in human colon cancer cells. Life Sciences. 91(15-16). 789–799. 15 indexed citations
16.
Venkatesan, P., et al.. (2012). Improved HPLC method with the aid of chemometric strategy: determination of loxoprofen in pharmaceutical formulation.. PubMed. 59(2). 242–8. 6 indexed citations
17.
Venkatesan, P., Nagaprasad Puvvada, Rupesh Dash, et al.. (2011). The potential of celecoxib-loaded hydroxyapatite-chitosan nanocomposite for the treatment of colon cancer. Biomaterials. 32(15). 3794–3806. 215 indexed citations
18.
Venkatesan, P., Soumen Das, M. Muthu Rama Krishnan, et al.. (2009). Effect of AEE788 and/or Celecoxib on colon cancer cell morphology using advanced microscopic techniques. Micron. 41(3). 247–256. 24 indexed citations
19.
Thangavel, Sivakumar, P. Venkatesan, R. Manavalan, & Valliappan Kannappan. (2007). Development of a HPLC method for the simultaneous determination of losartan potassium and atenolol in tablets. Indian Journal of Pharmaceutical Sciences. 69(1). 154–154. 29 indexed citations
20.
Ramachandran, Geetha, A. K. Hemanth Kumar, Soumya Swaminathan, et al.. (2006). Simple and rapid liquid chromatography method for determination of efavirenz in plasma. Journal of Chromatography B. 835(1-2). 131–135. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026